|
Gene expression-based personalized prescription of targeted drugs in colorectal cancer. |
|
|
|
|
Stock and Other Ownership Interests - Vitamed |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
|
|
|
No Relationships to Disclose |
|
|
Employment - Medical Holding SM-clinic |
|
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |